AB Corporate Bond ETF Stock Price, News & Analysis
Company Description
AB Corporate Bond ETF (NASDAQ: EYEG) is a publicly traded company in the Pharmaceutical Preparations sector.
EYEG stock has gained 0.5% over the past year. Shares last traded at $34.97.
This page provides a comprehensive overview of EYEG stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AB Corporate Bond ETF (EYEG) stock last traded at $34.97. Over the past 12 months, the stock has gained 0.5%.
Latest News
AB Corporate Bond ETF has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management, acquisition, conferences, clinical trial, earnings. View all EYEG news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in AB Corporate Bond ETF (EYEG) currently stands at 549 shares, up 385.8% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 58%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for AB Corporate Bond ETF (EYEG) currently stands at 2.1 days. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 81.6% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 102.0 days.
EYEG Company Profile & Sector Positioning
AB Corporate Bond ETF (EYEG) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.